Dr RR Baliga's "Got Knowledge Doc" Podkast

🚨 Calcific Aortic Valve Stenosis (CAVS): Beyond Wear and Tear 🫀🪨

Once thought to be "degenerative," CAVS is now recognized as an active disease driven by oxidative stress ⚡, inflammation 🔥, and lipoprotein(a) 🧬. Despite its growing global burden, no drug therapy slows its progression.

🩺 Current management: Surgical (SAVR) or Transcatheter (TAVR) valve replacement.

💊 Emerging hope: PCSK9 inhibitors, Lp(a) lowering agents, SGLT2 inhibitors, soluble guanylate cyclase activators, and anti-inflammatory strategies.

📊 Modern tools: Aortic valve calcification on CT, PET imaging for microcalcification, and strain imaging for early detection.

🔑 Takeaway: CAVS is preventable in theory, but not yet in practice. Novel therapeutics may finally reshape its natural history.

#Cardiology #HeartValve #PrecisionMedicine #AorticStenosis

🚨 New in The Lancet (2025) 🚨

A mega meta-analysis of 484 RCTs (104K+ participants) offers a game-changing approach to hypertension management! 💊📉

Instead of guessing how much BP will drop, now you can predict it—by drug, dose, and combo! 🎯

Like statins for LDL, this study introduces low-, moderate-, and high-intensity BP regimens based on expected mmHg reductions. 💡

Use the free calculator 🔢 at www.bpmodel.org and rethink the "measure-treat-measure" loop.

🩺 Data-driven. Predictable. Efficient. Just what primary care and cardiology need.

#Hypertension #BloodPressure #Cardiology #MetaAnalysis #PrecisionMedicine #Lancet2025 #BPcalculator #MedTwitter #InternalMedicine #DigitalHealth 💻📊🧬

🧒❤️ Partial Heart Transplant: A Growing Solution for Growing Hearts! 🌱🔬

🚨 Pediatric patients with congenital heart valve disease often face multiple surgeries due to non-living valve grafts that don't grow. This landmark study from @DukeHealth shows how living valves via partial heart transplant can change the game.

📊 In 19 patients (median age: 97 days), transplanted valves showed true annular and leaflet growth — with low immunosuppression and no valve-related reinterventions. The innovative "Living Ross" approach offers a promising path for long-term durability.

🧬 Organ stewardship, reduced surgeries, and biologic adaptation — the future is here.

🔗 Read the full JAMA study

#PediatricCardiology #HeartTransplant #InnovationInSurgery #LivingRoss #JAMA #CardiacSurgery #ValveReplacement #CongenitalHeartDisease #PartialHeartTransplant #PrecisionMedicine 🫀📈

🐖🫁 World First: Pig Lung Transplanted into Human 🧬🌍

In a groundbreaking step for xenotransplantation, a team in China successfully transplanted a genetically modified pig lung into a brain-dead human recipient. The lung functioned for 216 hours without hyperacute rejection, offering hope to thousands on organ waitlists.

🔬 Key breakthroughs:

• 6-gene-edited donor pig

• No Porcine Endogenous Retrovirus (PERV-C) detected 🦠

• Controlled immune response 🛡️

• PGD observed but stabilized 💉

📖 Published in Nature Medicine: https://doi.org/10.1038/s41591-025-03861-x

👏 A monumental leap toward clinical trials and saving lives.

#Xenotransplantation #LungTransplant #OrganDonation #Immunology #PrecisionMedicine #NatureMedicine #TranslationalScience 🚀

🧬 Pre-Heart Failure? Let Age Speak! 👵👴

New study in JACC compares fixed vs age-adjusted NT-proBNP cutoffs for defining pre–heart failure (Pre-HF) in over 22,000 adults across ARIC, MESA, and CHS cohorts.

📉 Key Insight: Age-adjusted cutoffs reduce overdiagnosis in older adults 🧓 and improve risk prediction for heart failure hospitalization 🏥.

📊 With better C-statistics, NRI, IDI, and a lower number needed to screen, the age-specific approach proves more precise—especially in those ≥75 years.

⚖️ One-size-fits-all doesn't fit the aging heart. Time to tailor biomarkers by age! ⏳❤️

#HeartFailure #NTproBNP #Cardiology #PrecisionMedicine #Biomarkers #PreventiveCardiology #JACC #PreHF #RiskStratification #PopulationHealth

🚨 Game-Changer in Lung Cancer! 🫁💉

The 5-year results from CheckMate 816 are in! Neoadjuvant nivolumab + chemotherapy significantly improved survival in resectable NSCLC 🎯

✅ 65.4% 5-year OS vs. 55.0% with chemo alone

🧬 pCR = 95.3% survival

📉 ctDNA clearance = better outcomes

⚖️ Time to rethink neoadjuvant strategies

📚 Read in NEJM: A landmark in thoracic oncology!

#LungCancer #Immunotherapy #NSCLC #Nivolumab #Oncology #CancerResearch #PrecisionMedicine

🚨 New insights from EHJ 2025! 🚨

In statin-treated patients undergoing PCI, inflammation (hsCRP ≥2 mg/L)—not elevated LDL-C—was the strongest predictor of MACE at 1 year 🔥🧪

📊 Bay et al. show that residual inflammatory risk carries a 1.8x higher hazard for adverse events, while LDL-C alone showed no independent risk 💥

🧠 Time to shift focus beyond lipids: consider anti-inflammatory therapies, remnant cholesterol, and Lp(a) in risk stratification 🩺🎯

📖 Read the study ➡️ https://doi.org/10.1093/eurheartj/ehaf196

#Cardiology #Inflammation #ResidualRisk #PCI #Statins #PrecisionMedicine

🔎 Averroes (Ibn Rushd, 1126–1198), the "Father of Rationalism," bridged Islam & the West through philosophy, medicine & law. 🌍

His commentaries on Aristotle, theory of the intellect, and medical insights (stroke, Parkinson's, retina) shaped centuries of thought.

📚 His legacy reminds us that reason, faith & science can coexist in pursuit of truth.

💡 #Philosophy #Medicine #History

🚨 New Study Alert 🧬🫀

Think a CAC score of zero means you're in the clear? Think again.

A massive cohort from the Western Denmark Heart Registry (n = 23,777) shows that elevated LDL-C is strongly associated with non-calcified plaque 🧱 and future coronary events 💥—even in those with CAC = 0.

📈 Each 1 mmol/L (~39 mg/dL) rise in LDL-C increases the odds of plaque (aOR 1.21) and risk of CHD (aHR 1.28).

🔥 Risks were highest in individuals ≤45 years—a silent threat during prime decades of life.

💡 Takeaway: No calcium ≠ No risk. LDL-C still drives subclinical disease.

👩‍⚕️👨‍⚕️ Time to rethink statin strategy in younger adults with "reassuring" scans.

📚 Read more in European Heart Journal (2025):

👉 https://doi.org/10.1093/eurheartj/ehaf497

#LDL #CAC #Cardiology #Atherosclerosis #CHD #Prevention #Lipidology #CCTA #PrecisionMedicine #Statins #EHJ #SubclinicalDisease #CardioLinked

🚨 New in NEJM 🫁: The IMPALA-2 trial shows that inhaled molgramostim significantly improves gas exchange, quality of life, and exercise capacity in patients with autoimmune pulmonary alveolar proteinosis (aPAP)—a rare disease driven by GM-CSF autoantibodies.

💨 Say goodbye to whole-lung lavage—this is a bench-to-bedside success story 30 years in the making.

🔬 From GM-CSF knockout mice ➡️ inhaled cytokine therapy ➡️ regulatory-grade RCT.

🏆 A major win for translational respiratory medicine.

#Pulmonology #RareDiseases #GMCSF #AutoimmuneDisease #Molgramostim #PrecisionMedicine #TranslationalResearch #NEJM #aPAP #LungHealth #RCT #CytokineTherapy #BenchToBedside #InhaledTherapy 🧬🫁💊